PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma
- 24 April 2023
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 25 (5) , 765-777
Abstract
PBRM1 encodes an accessory subunit of the PBAF SWI/SNF chromatin remodeller, and the inactivation of PBRM1 is a frequent event in kidney cancer. However, the impact of PBRM1 loss on chromatin remodelling is not well examined. Here we show that, in VHL-deficient renal tumours, PBRM1 deficiency results in ectopic PBAF complexes that localize to de novo genomic loci, activating the pro-tumourigenic NF-κB pathway. PBRM1-deficient PBAF complexes retain the association between SMARCA4 and ARID2, but have loosely tethered BRD7. The PBAF complexes redistribute from promoter proximal regions to distal enhancers containing NF-κB motifs, heightening NF-κB activity in PBRM1-deficient models and clinical samples. The ATPase function of SMARCA4 maintains chromatin occupancy of pre-existing and newly acquired RELA specific to PBRM1 loss, activating downstream target gene expression. Proteasome inhibitor bortezomib abrogates RELA occupancy, suppresses NF-κB activation and delays growth of PBRM1-deficient tumours. In conclusion, PBRM1 safeguards the chromatin by repressing aberrant liberation of pro-tumourigenic NF-κB target genes by residual PBRM1-deficient PBAF complexes.Keywords
Funding Information
- Agency for Science, Technology and Research
- MOH | National Medical Research Council (MOH-000232, OFIRG19nov-0106, NMRC MOH-000248-00)
- St. Baldrick’s Foundation
- National Research Foundation Singapore (NRF-CRP22-2019-0003, NRF-CRP23-2019-0004)
This publication has 53 references indexed in Scilit:
- NF-κB Forms a Complex with the Chromatin Remodeler BRG1 to Regulate Schwann Cell DifferentiationJournal of Neuroscience, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- Differential oestrogen receptor binding is associated with clinical outcome in breast cancerNature, 2012
- Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB–Dependent Transcription and Induction of Apoptosis in CTCLMolecular Cancer Research, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Model-based Analysis of ChIP-Seq (MACS)Genome Biology, 2008
- BAF180 Is a Critical Regulator of p21 Induction and a Tumor Suppressor Mutated in Breast CancerCancer Research, 2008
- Phase II Trial of Bortezomib for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2004
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997